Abstract: Tanycytes are radial glial cells located in the mediobasal hypothalamus. Recent studies have proposed that tanycytes play an important role in hypothalamic control of energy homeostasis, although this has not been directly tested. Here, we report the phenotype of mice in which tanycytes of the arcuate nucleus and median eminence were conditionally ablated. Although the CSF-hypothalamic barrier was rendered more permeable, the blood-hypothalamic barrier was not altered. The metabolic effects of tanycyte ablation were likewise moderate. However, we consistently observed a significant increase in visceral fat distribution accompanying insulin insensitivity, but only in male mice, and without an effect on either body weight or food intake. A high-fat diet accelerated overall body weight gain in tanycyte-ablated mice, but the development of visceral adiposity and insulin insensitivity was attenuated. These results clarify the extent to which tanycytes regulate energy metabolism, and indicate a role for tanycytes in controlling body adiposity.
we observed a rapid, selective and essentially complete ablation of tanycytes of the arcuate nucleus and median eminence (ArcN-ME), which represent all beta-tanycytes, as well as a subset of alpha-2 tanycytes. We have used these mice to directly investigate the roles of tanycytes of the ArcN-ME in acute regulation of hypothalamic barrier function, leptin signaling, neurohormone release, fat distribution, insulin sensitivity and energy balance.
blood-hypothalamic barrier permeability, as measured by Evan Blue staining after i.v. delivery, with reduced absolute levels of ME staining which mainly reflected the overall reduction in ME volume that is seen in tanycyte-ablated mice ( Fig. 2A & B) . In contrast, i.c.v. delivery of Evans Blue demonstrated substantially increased permeability in ArcN of tanycyte-ablated mice, while the staining in the ME was still strong near the ventricular floor ( Fig. 2C & D) .
Immunostaining for the tight junction marker ZO-1, which is expressed in tanycytes and reported to maintain hypothalamic barrier function, is lost in both ArcN and ME tanycytes in RaxCreER;Eno2-lsl-DTA mice (Fig. 2E & F) . In contrast, Vimentin immunoreactivity is increased in the ventricular zone of the ME (Fig. 2E' & F' ). This is also seen for GFAP immunostaining (Fig. 1F) , indicating reactive astrogliosis. Immunostaining for MECA32, a marker of fenestrated capillaries, revealed no change in the number of immuno-positive cells in ME between the two groups (Fig. 2F) . Together, these data demonstrate that, while tanycytes are necessary for maintenance of the CSF-hypothalamus barrier, they are not required to maintain the blood-hypothalamus barrier.
A previous report suggested that beta-2 tanycytes were involved in active transcytosis of leptin from blood to the hypothalamus [18] . Our recent study, however, has demonstrated that leptin receptors are not detectably expressed in tanycytes, and are not required for leptin transport into hypothalamus [26] . To further investigate whether tanycytes of the ArcN-ME might regulate hypothalamic leptin signaling, we performed intraperitoneal (i.p.) leptin injection in both control and tanycyte-ablated mice. We observed no differences in pSTAT3 staining in neurons of any hypothalamic region that were directly in contact with tanycytes ( Fig. 3A & B) . This data further confirms that tanycytes are not involved in active transport of leptin from blood to the hypothalamus.
3. Ablation of ArcN-ME tanycytes led to increased fat mass without body weight change, particularly in male mice.
To more broadly investigate the contribution of tanycytes of the ArcN-ME to energy balance and other metabolic outcomes, we first analyzed food intake and body weight in control and tanycyte-ablated mice. We initially used a prolonged tamoxifen treatment to investigate the potential cumulative effects of loss of both tanycytes and tanycyte-derived cells, in both males and female mice. Both control and tanycyte-ablated mice were fed dietary tamoxifen for a period of over 50 days (Fig. 4A ). While no difference in body weight was observed, a significant increase in fat mass was observed in male, but not in female mice, within 4 weeks following initiation of the tamoxifen diet ( Fig. 4B-F) . In particular, males had a substantial increase in perigonadal fat mass (Fig. 4G) .
The increase in fat content in male mice seen within 4 weeks after initiating tamoxifen diet prompted us to investigate whether this effect was the result of acute tanycyte ablation, rather than cumulative effects of long-term ablation. Following 3 weeks of tamoxifen diet (as described in Fig.1B) , we also did not observe differences in body weight during tamoxifen administration, or in the 2 weeks of return to control diet in male mice (Fig.  4H ). However, a clear increase in body fat content was observed, while lean body mass was not affected (Fig. 4I & J) . Increased perigonadal and retroperitoneal fat depots were observed, with a similar trend for inguinal fat (p=0.05) (Fig. 4K) . Perigonadal adipocytes were larger in tanycyte-ablated mice than in wildtype mice (Fig. 4M) . We did not find significant differences in brown adipose tissue (Fig. 4K ) or in the sizes of any other internal organs between the two mouse groups (Fig. 4L ).
Increased fasting-induced food intake and reduced insulin sensitivity is observed in ArcN-ME tanycyte-ablated male mice
In order to explore responses to states of negative and positive energy balance, we measured food intakes in control and tanycyte-ablated animals fed ad libitum, and then refed after an overnight food deprivation, during the long-term ablation (Fig.5A) . In male mice maintained on tamoxifen for 4 weeks, no differences in food intake were observed in mice fed ad libitum, or following refeeding after the fast (Fig. 5B) , indicating that food intake was not altered in the early phase of fat accumulation. However, after 8 weeks of tamoxifen treatment, male tanycyte-ablated mice showed hyperphagia, particularly in response to food deprivation (Fig. 5C) .
To further investigate mechanisms that might contribute to the hyperphagia, we analyzed blood hormone levels in male mice subjected to both short-and long-term tamoxifen treatments. Mice that underwent either short-term or long-term tamoxifen treatment showed significant increase in serum leptin, consistent with the increased fat contents, but showed no change in serum insulin ( Fig. 5D & E) . Satiety hormones from gut, pancreatic polypeptide (PP) and peptide YY (PYY), were increased significantly in tanycyteablated mice following long-term tamoxifen treatment ( Fig. S3A & B) . No changes were observed in serum levels of leptin and insulin in females (Fig. S2C) .
We did not observe effects on glucose tolerance after tanycyte ablation induced by short-term or long-term tamoxifen treatments ( Fig. 5F & H) . However, tanycyte-ablated male mice exhibited substantially reduced sensitivity to insulin under both conditions ( Fig. 5G & I) , consistent with the increased adiposity in these animals . In contrast, females exhibited no differences in food intake, glucose tolerance or insulin sensitivity (Fig. S2A,B 
,D & E).
To further investigate the mechanisms mediating the acute increase in fat contents, and to test the more general role of tanycytes in regulation of release of hypothalamic and pituitary hormones, we expanded our analysis to test serum levels of a broad panel of factors (Fig. S3, S4 & S5) . Surprisingly, few consistent changes in hormone levels were observed. Significant increases in serum TSH and neurotensin levels were observed in tanycyte-ablated mice following short-term treatment (Fig.S4J & O) , although neither hormone was affected in tanycyte-ablated mice following long-term tamoxifen treatment ( Fig.  S3J & O) . Because tanycytes produce thyroid hormone converting enzyme [29] , and have been linked to regulation of TRH release from hypothalamic neurosecretory cells [9, 19, 30] , we further investigated whether short-term tanycyte-ablation compromised the response of the hypothalamic-pituitary-thyroid axis to an acute cold challenge. While serum TSH levels were consistently elevated following 2 hour cold exposure, no significant difference was observed between control and tanycyte-ablated mice (Fig. S6) .
Decreased serum oxytocin levels were observed in tanycyte-ablated mice following long-term tamoxifen treatment (Fig. S3M) . No changes were observed in serum hormone levels in females (Fig.S5) , with the surprising exception of growth hormone (GH), which showed two-fold higher levels following tanycyte-ablation (Fig. S5J) . Since females do not show an overall increase in body weight or lean mass, the significance of this observation is unclear.
To further investigate the mechanism underlying the adiposity observed in tanycyteablated mice, we conducted indirect calorimetry studies on male mice that had undergone short-term tanycyte ablation (Fig.S7A) . As observed previously, there were no differences in body weight or caloric intake between controls and tanycyte-ablated mice (Fig. S7B & C) . Likewise, there were no differences in VO 2 (or VCO2, data not shown) or rates of energy expenditure ( Fig. S7E & F) . However, a close examination of respiratory exchange ratio (RER) suggested a subtle shift away from fat oxidation, during the later portion of the dark phase and during the light phase, when compared to control mice (Fig. S7D ).
Effects of high-fat diet on tanycyte-deficient male mice
The increased fat contents and decreased insulin sensitivity in tanycyte-deficient mice that had been fed a low-fat diet raised the possibility that these effects might be enhanced on an obesogenic high-fat diet (HFD). To address this, we placed both control and tanycyte-ablated male mice on a high-fat diet immediately following 3 weeks of feeding with tamoxifen-supplemented low-fat diet (Fig. 6A) . Tanycyte-ablated mice showed increased body weight gain on HFD compared with control mice (Fig. 6B ). HFD produced a robust increase in overall fat mass in both groups, but tanycyte-ablated mice showed statistically greater overall fat mass than wildtype mice (Fig. 6C) . However, none of the individual depots of white adipose tissue showed increased mass in tanycyte-ablated mice compared with controls ( Fig. 6D) , in contrast to the substantial increases seen in ablated mice maintained on regular low-fat tamoxifen diet (Fig. 4K) .
Unlike ablated mice maintained only on low-fat tamoxifen diet ( Fig. 5H ), HFD-fed tanycyte-deficient mice showed slight but significant improvements in glucose tolerance at early time points ( Fig. 6F & G), consistent with increased serum insulin 15 min after glucose injection (Fig. 6H ). Tanycyte-ablated male mice showed prolonged effects of insulin action in an insulin tolerance test on HFD ( Fig. 6I & J) . This effect was also more moderate than that observed on regular tamoxifen diet which showed decreased insulin sensitivity at earlier time points than mice on high-fat tamoxifen diet. (Fig. 5I) .
Discussion:
In this study, we have investigated the cellular and physiological effects of selective ablation of tanycytes of the ArcN and ME. Although tanycytes in these hypothalamic regions have been proposed to control a broad range of physiological processes, including blood-hypothalamic barrier formation, control of hypothalamic leptin signaling and regulation of the neuroendocrine axis, our findings revealed surprisingly subtle phenotypes in tanycyte-ablated mice, which is primarily restricted to a male-specific increase in adiposity and a decreased insulin sensitivity, without body weight change.
Perhaps most surprisingly, complete ablation of beta-tanycytes did not lead to an increased permeability of the blood-hypothalamus barrier, although it led to a clear increase of Evans Blue permeability from the CSF into the ArcN parenchyma, along with minor leakage into the ME. This is consistent with a previous report that tanycytes regulate CSFhypothalamic barrier function [28] . This likely implies a central role for other cell types, such as endothelial cells and pericytes, in regulating permeability between the ArcN and ME. The finding that hypothalamic leptin signaling was unaffected by absence of beta-tanycytes is consistent with our recent findings that LepR expression in tanycytes is not necessary for leptin transport from blood to hypothalamic parenchyma [26] .
We likewise observed only modest and transient effects on the neuroendocrine axis. beta-tanycyte have been implicated in active regulation of both GnRH and TRH synthesis and/or release [8, 9, 30] . Tanycyte foot processes have been reported to physically inhibit GnRH release in female, but to retract during estrus to allow GnRH release into the portal circulation [8, 31] . While we did not observe significant changes in serum levels of FSH or LH in either sex, these results are difficult to interpret due to disruptive effects of prolonged tamoxifen exposure on the hypothalamic-pituitary-gonadal axis.
Beta-tanycytes strongly express Dio2, an enzyme that converts T4 to T3, which is known to negatively regulate transcription of Trh [32] . Furthermore, beta-tanycytes release exoenzymes which degrade TRH [19, 30] . One might therefore predict that ablation of betatanycytes would lead to a global activation of the hypothalamic-pituitary-thyroid (HPT) axis [33] . We did not, however, observe any obvious changes in hypothalamic Trh expression in tanycyte-ablated mice (Fig. S1 ). While we observed an increase in serum TSH in male mice subjected to short-term tanycyte ablation (Fig. S4) , consistent with HPT hyperactivation, no significant change in serum TSH was observed in either male mice subjected to longer-term tanycyte ablation or in female mice (Fig. S3 & 5) . Furthermore, we did not observe statistically significant differences in elevated serum levels of TSH following acute cold exposure between the control and tanycyte-ablated mice (Fig. S6 ). This suggests that any role beta-tanycytes play in regulating the HPT is relatively modest and also sex-specific, and that disruption of beta-tanycyte function is rapidly compensated for by changes in other tissues.
Beta-tanycytes have been reported to sense glucose and amino acids [15] [16] [17] , and have been proposed to act as essential central integrators of metabolic regulation [5, 13, 14] . Nevertheless, tanycyte ablation did not result in dramatic changes in regulation of energy balance in normal and obesogenic dietary conditions. Tanycyte-ablated mice did not show changes in overall body weight or food intake in the 4 weeks following tanycyte ablation. However, we observed a significant increase in adiposity, that is most prominent in visceral fat, in male mice at this stage ( Fig. 4G & K) . Within 4 weeks following tanycyte ablation, decreased insulin sensitivity was observed, along with increased serum leptin levels. However, glucose tolerance was unaffected, suggesting that these changes may be secondary to the increased adiposity. In females, however, no significant changes in adiposity, serum leptin and insulin sensitivity were observed (Fig. 4E & Fig. S2 ). The molecular mechanisms underlying these acute metabolic changes and their sexual dimorphism are yet unclear. However, the data suggest that there is a direct or indirect involvement of tanycytes in control of fat utilization, as shown by the slightly higher RER overall during typically fat-oxidizing phases of the photoperiod in tanycyte-deficient male mice (Fig. S7D) .
Increased adiposity in males became more prominent at 7 weeks following tanycyte ablation, and yet still without overall body weight change (Fig. 4B & C) . This was accompanied by an exacerbated hyperphagic response to prolonged fasting, although ad libitum food intake was unaffected (Fig. 5C ). This enhanced re-feeding implies that longerterm tanycyte ablation disrupts both normal central integration and the response to signals of negative energy balance. This could result from a variety of mechanisms, ranging from the absence of sensation of small molecules by tanycytes to the disruption of generation of tanycyte-derived neurons or glia [11, 17] .
In conclusion, tanycytes of the ArcN-ME have a specific role in fat metabolism rather than food intake and body weight control which would be more closely related to the physiological functions of tanycytes recently reported [7, 9, 13] . This does not rule out a potentially important role for tanycytes in influencing these processes, but demonstrates that other cells can compensate for the loss of tanycyte function. It also remains possible that the residual tanycytes, which would be alpha-1 and a subset of alpha-2 subtypes, could be major players in the expected metabolic phenotypes [34, 35] Furthermore, we have only tested a limited number of potential environmental conditions, and a more prominent role for tanycytes may be revealed in response to other physiological challenges. Finally, there are many other physiological processes that may be tanycyte-regulated that were not tested in this study. Notably, tanycytes have been reported to play a critical role in biological timing and reproductive regulation in species that show strong photoperiodism [36] [37] [38] , and it is possible that related behaviors may be under tanycyte-dependent regulation in mice.
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Materials and Methods: Animals
Rax-CreERT2 mice gene were generated in the laboratory were crossed with Ai9 (R26-CAG-lsl-tdTom, JAX #007909) [20] (JAX#025521), and then bred with Eno2-lsl-DTA mice [39] to induced the tanycyte-specific ablation. To induce Cre recombination, the mice were fed with commercial tamoxifen-containing diet (250 mg/kg diet, Envigo Teklad diets #TD. 130856) starting at P42 for the indicated periods of time to produce and maintain the tanycyte ablation. To aid acclimation from regular diet presented at weaning (TD.2018, 3.1 kcal/g; 24 kcal% protein, 18 kcal% fat, 58 kcal% carbohydrate) to the tamoxifen-containing diets, mice were fed from P35 until P42 on a diet that was the same energy density, but with macronutrients otherwise matched to the subsequent tamoxifen-containing diet (control diet without tamoxifen: 3.1 kcal/g; 19.7 kcal% protein, 70.6 kcal% carbohydrate, 9.7 kcal% fat)(Envigo Teklad diet #TD. 07570). For the short-term ablation study, the mice were switched back to this control diet after 3 weeks, for the physiological phenotyping. For the high-fat diet feeding experiments, customized tamoxifen diets were based on either a veryhigh-fat diet (Research Diets, 5.2 kcal/g; 20 kcal% protein, 20 kcal% carbohydrate, 60 kcal% fat, supplemented tamoxifen at 403.1 mg/kg) or on a low-fat diet (Research Diets, 3.8 kcal/g; 20 kcal% protein, 70 kcal% carbohydrate, 10 kcal% fat supplemented with 248 mg/kg diet). Mice were initially housed in a specific pathogen free facility on a 14 h-10 h light/dark cycle (07:00 lights on -19:00 lights off). One week prior to physiological studies, mice were transferred to the rodent metabolism core satellite facility at the Center for Metabolism and Obesity Research to acclimate to its vivarium on 12 h -12 h light dark cycle (06:00 lights on -18:00 lights off climates at both facilities were controlled within temperature and humidity ranges consistent with the Guide for the Care and Use of Laboratory Animals (8th ed.). All studies and procedures were performed under a pre-approved protocol by the Institutional Animal Care and Use Committee (IACUC) of the Johns Hopkins University School of Medicine.
Tissue processing and Immunohistochemistry
Mice were anesthetized with intraperitoneal (i.p.) injection of Tribromoethanol/Avertin before transcardial perfusion with 1X PBS followed by 2% paraformaldehyde in 1X PBS. Brains were dissected and post-fixed in the same fixative for overnight at 4°C. After brief washing with 1X PBS, brains were incubated in 30% sucrose until brains sunk, then transferred and incubated in a 50:50 solution of 30% sucrose: O.C.T. embedding compound before being frozen. Brains were coronally sectioned at 25 µm thickness using a cryostat (Leica Biosystems) and stored in antifreeze solution at -20°C.
Sections were mounted on the Superfrost Plus slides (Fisher Scientific) before immunohistochemistry was conducted, and dried at room temperature for 30 min. For pSTAT3 staining, sections were sequentially incubated with 0.5% NaOH + 0.5% H 2 O 2 for 20 min, 0.3% glycine for 10 min, and 0.03% SDS for 10 min, and blocked in 4% sheep serum/ 1% BSA/ 0.4% Triton X-100 in PBS for 1 hour at room temperature. Otherwise, sections were incubated with sodium citrate buffer (10mM Sodium citrate, pH 6.0) at 80°C for 30 min for antigen retrieval. After cooling for another 30 min at room temperature, sections were blocked in 10% sheep serum/ 0.1% Triton X-100 in PBS for 1 hour at room temperature. The sections imaged for Evans Blue staining were immediately treated with blocking solution before primary antibody incubation. After counterstaining with DAPI, sections were coverslipped using Vectashield antifade mounting medium (# H-1200, Vector Laboratories) before imaging on a Zeiss LSM 700 Confocal at the Microscope Facility (Johns Hopkins University School of Medicine).
In situ hybridization
Chromogenic in situ hybridization was performed on fresh-frozen brain tissue as previously described [40, 41] . Briefly, coronal 25 µm sections were prepared using a cryostat and fixed with 4% paraformaldehyde. After acetylation with triethanolamine (0.1M, pH 8.0) and acetic anhydride mixture (0.27%), sections were hybridized with digoxigenin-labeled probes at 70°C overnight. Unbound probes were washed out and sections were blocked with sheep serum followed by incubation with anti-digoxigenin antibodies conjugated to alkaline phosphatase (1:5000) overnight at 4°C. The combination of nitro-blue tetrazolium (NBT) and 5-bromo, 4-chloro, 3-indolylphosphate (BCIP) was used as chromogenic substrates of alkaline phosphatase. Color development was continued in the same amount of time between wildtype and tanycyte-ablated sections.
Evans Blue injection
Mice given 2-3 weeks of reversion to matched control diet, after the 3 weeks of tamoxifen diet, were injected with sterile 1% Evans Blue dye in 0.9% saline through either intravenous (i.v.; 50µl) or intracerebroventricular (i.c.v.; 2µl) [4] . For i.v. injections, mice were decapitated 20 min after tail vein injections, and brains was dissected and immediately frozen in O.C.T. embedding compound. For i.c.v. injections, Evans Blue is injected into the lateral ventricle (y: -0.3 mm, x: -1mm, z: 2.5 mm) of anaesthetized mice (100 mg/kg ketamine, 10 mg/kg xylazine and 3 mg/kg acepromazine) using an infusion pump with 10-ul Hamilton syringe for 1 min. Infusion was confirmed by Evans Blue dye diffusion into the opened cisterna magna during the injection and the needle was removed 1 min after finishing the injection. The snap-frozen brains were coronally sectioned at 25 µm thickness and directly imaged under a fluorescent microscope (Keyence BZ-X700). The sections were then fixed in methanol/acetone (v/v) at -20°C for 1 min and further used for the immunohistochemistry as described above.
Leptin injection
Leptin injection was performed as previously described [26] . Briefly, 3 mg/kg leptin was injected i.p., and 15 min later transcardial perfusion was performed with 1X PBS followed by 2% paraformaldehyde in 1X PBS. Previous studies of leptin-induced hypothalamic STAT3 phosphorylation studies [26, 42, 43] led us conclude that, if there is any leakage through the opened CSF-hypothalamus or blood-hypothalamus barrier, this would be evident within 15 min following leptin injection.
Fasting-refeeding food intake study Tamoxifen-fed male and female mice were individually housed and initially provided ad libitum access to water and food, in a vivarium on a 12 h-12 h light/dark cycle. A wire mesh floor was inserted into the home cage to collect spilled food onto a cage paper beneath the mesh. For the fasting-refeeding experiment, both groups of animals were fasted 18h (beginning halfway through the dark phase), and then refed for 24h (beginning at the start of the next dark phase). Food intake (corrected for dry, feces-free spillage) was measured at 1, 3, 6, and 24 hour time points during the course of refeeding. The ad libitum food intake data was obtained one day prior to the fast-refeed study with the same procedure used for food intake measurement.
Luminex assay and ELISA
Mouse serum samples were collected from tail vein at between 14:00h and 16:00h. After brief exposure to heat to promote blood vessel dilation, the collection site was cleaned with 70% alcohol, and the mouse is restrained. Blood was collected using a sterile surgical blade (#12-460-440, Fisher Scientific) from the lateral tail vein. Blood flow was stopped by applying pressure with sterile gauze to achieve hemostasis. Metabolic hormone, pituitary hormone, and neuropeptide serum levels were measured by Luminex assay according to the manufacturer's instructions (#MMHMAG-44K, #MPTMAG-49K, and #RMNPMAG-83K from Millipore Sigma). Serum insulin and testosterone levels were measured using ELISA kit purchased from Millipore (#EZRMI-13K) and Crystal Chem (#80552), respectively. For the acute cold exposure study, mice were transferred to a room maintained at 4°C for 2 hours at between 14:00 h and 16:00h. Blood was briefly collected immediately after cold exposure from the submandibular vein. Serum TSH levels were measured using ELISA kit purchased from Cloud-Clone Corp. (#CEA463Mu).
Body composition analysis, Indirect calorimetry
Fat and lean masses were determined using a whole-body NMR instrument (EchoMRI, Waco, TX) at the Phenotyping Core of the Johns Hopkins University School of Medicine. Indirect calorimetry was conducted using a Comprehensive Lab Animal Monitoring System (Columbus Instruments) in the rodent metabolism core facility at the Center for Metabolism and Obesity Research of the Johns Hopkins University. Mice were acclimated and monitored in the individual test chambers for days, with a fourth day for data reporting.. Daily body weights and food intakes (corrected for spillage) were measured. Oxygen consumption (VO 2 , mL/kg/h) and carbon dioxide production (VCO 2 , mL/kg/h) were measured for each chamber every 10 min. Oxymax software (v. 4.02) calculated RER (VCO 2 /VO 2 ) and energy expenditure (EE = CV x VO 2 , CV = 3.815 + (1.232 x RER)..
Glucose and insulin tolerance tests (GTT, ITT)
For the glucose tolerance test, animals were fasted for 12 hours, and 0.1g/kg glucose was injected i.p.. Blood glucose levels during the test were measured using the tail-nick method and a glucometer (Novamax).In addition, up to 25 ul of blood was collected to obtain serum for insulin measurements with an ELISA kit. For the insulin tolerance test, food was removed 2 hour prior to 0.8 units/kg body weight insulin injection, and blood glucose was measured with a glucometer.
Cell counting and statistical analysis
All pSTAT3 and HuC/D-double positive cell counts was performed blinded and blindly and manually, as performed described in our previous study [26] . The size (mm) of each hypothalamic nucleus and the length of tanycytic layer or Evans Blue penetration depth were measured using Image-J. All values are expressed as means ± S.E.M. Comparison was analyzed by unpaired, two-tailed Student's t-test, and p< 0.05 was considered statistically significant. Immunostaining against the fenestrated capillary marker, MECA32 (green). Scale bar: 100 µm (A,C,F,H), 50 µm (F'). *p<0.05, **p<0.005. Area under the curve (AUC) quantification of (I). *p<0.05, **p<0.02, ***p<0.002.
